Impact of Fraction Size on Lung Radiation Toxicity: Hypofractionation may be Beneficial in Dose Escalation of Radiotherapy for Lung Cancers

International Journal of Radiation Oncology Biology Physics

Volumn 76, Issue 3, 2010, Pages 782-788

  Jin, Jin Yue ^a   Kong, Feng Ming ^b,c   Chetty, Indrin J ^a   Ajlouni, Munther ^a   Ryu, Samuel ^a   Ten Haken, Randall ^b   Movsas, Benjamin ^a  

^a HENRY FORD HOSPITAL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c Ann Arbor Health System   (United States)

Author keywords

Hypofraction; Non small cell lung cancer; Normal tissue complication probability; Radiobiology; Stereotactic body radiotherapy

Indexed keywords

COMPUTATIONAL STUDIES; CONVENTIONAL FRACTIONATIONS; DOSE EFFECTS; DOSE ESCALATION; DOSE-VOLUME HISTOGRAMS; FRACTION SIZE; HIGH DOSE; HYPOFRACTIONATION; LUNG CANCER; NON SMALL CELL LUNG CANCER; NORMAL TISSUE COMPLICATION PROBABILITIES; RADIATION TOXICITY; S-SHAPED; SINGLE PARAMETER; SMALL TUMORS; STEREOTACTIC BODY RADIOTHERAPY; THRESHOLD DOSE; TOTAL DOSE;

BIOPHYSICS; ONCOLOGY; RADIOACTIVITY; RADIOTHERAPY; SEMICONDUCTOR DOPING; TOXICITY; TUMORS;

BIOLOGICAL ORGANS;

ARTICLE; CANCER RADIOTHERAPY; HISTOGRAM; HUMAN; LUNG CANCER; LUNG TUMOR; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; TUMOR VOLUME;

DOSE FRACTIONATION; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MODELS, BIOLOGICAL; RADIATION INJURIES; RADIOSURGERY; TUMOR BURDEN;

EID: 76049093691     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.02.079     Document Type: Article

References (26)

1. Nagata Y., Negoro Y., Aoki T., et al. Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame. Int J Radiat Oncol Biol Phys 52 (2002) 1041-1046
2. Timmerman R., Papiez L., McGarry R., et al. Extracranial stereotactic radioablation: Results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 124 (2003) 1946-1955
3. Onishi H., Araki T., Shirato H., et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: Clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 101 (2004) 1623-1631
4. Zimmermann F.B., Geinitz H., Schill S., et al. Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC). Acta Oncol 45 (2006) 796-801
5. Hoyer M., Roed H., Hansen A.T., et al. Prospective study on stereotactic radiotherapy of limited-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 66 (2006) S128-S135
6. Beitler J.J., Badine E.A., El-Sayah D., et al. Stereotactic body radiation therapy for nonmetastatic lung cancer: An analysis of 75 patients treated over 5 years. Int J Radiat Oncol Biol Phys 65 (2006) 100-106
7. Matsuo Y., Takayama K., Nagata Y., et al. Interinstitutional variations in planning for stereotactic body radiation therapy for lung cancer. Int J Radiat Oncol Biol Phys 68 (2007) 416-425
8. Guckenberger M., Heilman K., Wulf J., et al. Pulmonary injury and tumor response after stereotactic body radiotherapy (SBRT): Results of a serial follow-up CT study. Radiother Oncol 85 (2007) 435-442
9. Kavanagh B.D., Scheftera T.E., and Wersäll P.J. Liver, renal, and retroperitoneal tumors: Stereotactic radiotherapy. Front Radiat Ther Oncol 40 (2007) 415-426
10. Timmerman R.D., Kavanagh B.D., Cho L.C., et al. Stereotactic body radiation therapy in multiple organ sites. J Clin Oncol 25 (2007) 947-952
11. Jin J.Y., Chen Q., Jin R., et al. Technical and clinical experience with spine radiosurgery: A new technology for management of localized spine metastases. Technol Cancer Res Treat 6 (2007) 127-133
12. Fowler J.F., Tomé W.A., Fenwick J.D., et al. A challenge to traditional radiation oncology. Int J Radiat Oncol Biol Phys 60 (2004) 1241-1256
13. Seppenwoolde Y., Lebesque J.V., de Jaeger K., et al. Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability. Int J Radiat Oncol Biol Phys 55 (2003) 724-735
14. Yorke E.D., Jackson A., Rosenzweig K.E., et al. Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. Int J Radiat Oncol Biol Phys 63 (2005) 672-682
15. Jin J.Y., Ajlouni M., Chen Q., et al. Quantification of incidental dose to potential clinical target volume (CTV) under different stereotactic body radiation therapy (SBRT) techniques for non-small cell lung cancer-tumor motion and using internal target volume (ITV) could improve dose distribution in CTV. Radiother Oncol 85 (2007) 267-276
16. Kwa S.L., Theuws J.C., Wagenaar A., et al. Evaluation of two dose-volume histogram reduction models for the prediction of radiation pneumonitis. Radiother Oncol 48 (1998) 61-69
17. Rodrigues G., Lock M., D'Souza D., et al. Prediction of radiation pneumonitis by dose-volume histogram parameters in lung cancer-a systematic review. Radiother Oncol 71 (2004) 127-138
18. Yorke E.D., Jackson A., Rosenzweig K.E., et al. Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys 54 (2002) 329-339
19. Kwa S.L., Lebesque J.V., Theuws J.C., et al. Radiation pneumonitis as a function of mean lung dose: An analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys 42 (1998) 1-9
20. Rancati T., Wennberg B., Lind P., et al. Early clinical and radiological pulmonary complications following breast cancer radiation therapy: NTCP fit with four different models. Radiother Oncol 82 (2007) 308-316
21. Tucker S.L., Liu H.H., Wang S., et al. Dose-volume modeling of the risk of postoperative pulmonary complications among esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 66 (2006) 754-761
22. Rosen I.I., Fischer T.A., Antolak J.A., et al. Correlation between lung fibrosis and radiation therapy dose after concurrent radiation therapy and chemotherapy for limited small cell lung cancer. Radiology 221 (2001) 614-622
23. Marks L.B., Munley M.T., Spencer D.P., et al. Quantification of radiation-induced regional lung injury with perfusion imaging. Int J Radiat Oncol Biol Phys 38 (1997) 399-409
24. Garipagaoglu M., Munley M.T., Hollis D., et al. The effect of patient-specific factors on radiation-induced regional lung injury. Int J Radiat Oncol Biol Phys 45 (1999) 331-338
25. Theuws J.C., Kwa S.L., Wagenaar A.C., et al. Dose-effect relations for early local pulmonary injury after irradiation for malignant lymphoma and breast cancer. Radiother Oncol 48 (1998) 33-43
26. Kong F.M., Hayman J.A., Griffith K.A., et al. Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): Predictors for radiation pneumonitis and fibrosis. Int J Radiat Oncol Biol Phys 65 (2006) 1075-1086